Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth.
Toyota Y, Iwama H, Kato K, Tani J, Katsura A, Miyata M, Fujiwara S, Fujita K, Sakamoto T, Fujimori T, Okura R, Kobayashi K, Tadokoro T, Mimura S, Nomura T, Miyoshi H, Morishita A, Kamada H, Yoneyama H, Okano K, Suzuki Y, Masaki T. Toyota Y, et al. Among authors: tadokoro t. Int J Oncol. 2015 Oct;47(4):1293-302. doi: 10.3892/ijo.2015.3118. Epub 2015 Aug 7. Int J Oncol. 2015. PMID: 26252371
Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
Takano J, Morishita A, Fujihara S, Iwama H, Kokado F, Fujikawa K, Fujita K, Chiyo T, Tadokoro T, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Kobara H, Mori H, Niki T, Hirashima M, Masaki T. Takano J, et al. Among authors: tadokoro t. Oncol Rep. 2016 Feb;35(2):851-60. doi: 10.3892/or.2015.4452. Epub 2015 Nov 26. Oncol Rep. 2016. PMID: 26717877
Galectin-9: An anticancer molecule for gallbladder carcinoma.
Tadokoro T, Morishita A, Fujihara S, Iwama H, Niki T, Fujita K, Akashi E, Mimura S, Oura K, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Himoto T, Hirashima M, Masaki T. Tadokoro T, et al. Int J Oncol. 2016 Mar;48(3):1165-74. doi: 10.3892/ijo.2016.3347. Epub 2016 Jan 19. Int J Oncol. 2016. PMID: 26797414
Diabetes mellitus and metformin in hepatocellular carcinoma.
Fujita K, Iwama H, Miyoshi H, Tani J, Oura K, Tadokoro T, Sakamoto T, Nomura T, Morishita A, Yoneyama H, Masaki T. Fujita K, et al. Among authors: tadokoro t. World J Gastroenterol. 2016 Jul 21;22(27):6100-13. doi: 10.3748/wjg.v22.i27.6100. World J Gastroenterol. 2016. PMID: 27468203 Free PMC article. Review.
Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs.
Fujita K, Iwama H, Oura K, Tadokoro T, Hirose K, Watanabe M, Sakamoto T, Katsura A, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Okano K, Suzuki Y, Himoto T, Masaki T. Fujita K, et al. Among authors: tadokoro t. Int J Mol Med. 2016 Oct;38(4):1135-40. doi: 10.3892/ijmm.2016.2729. Epub 2016 Sep 2. Int J Mol Med. 2016. PMID: 27600587 Free PMC article.
Cancer Therapy Due to Apoptosis: Galectin-9.
Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T. Fujita K, et al. Among authors: tadokoro t. Int J Mol Sci. 2017 Jan 1;18(1):74. doi: 10.3390/ijms18010074. Int J Mol Sci. 2017. PMID: 28045432 Free PMC article. Review.
Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma.
Chiyo T, Kato K, Iwama H, Fujihara S, Fujita K, Tadokoro T, Ohura K, Samukawa E, Yamana Y, Kobayashi N, Matsunaga T, Nishiyama N, Ayaki M, Yachida T, Morishita A, Kobara H, Mori H, Masaki T. Chiyo T, et al. Among authors: tadokoro t. Int J Oncol. 2017 Jun;50(6):2145-2153. doi: 10.3892/ijo.2017.3971. Epub 2017 Apr 20. Int J Oncol. 2017. PMID: 28440424
292 results